Adherence to mediterranean diet in patients with inflammatory bowel disease.


Journal

Clinical nutrition ESPEN
ISSN: 2405-4577
Titre abrégé: Clin Nutr ESPEN
Pays: England
ID NLM: 101654592

Informations de publication

Date de publication:
12 2021
Historique:
received: 01 04 2021
revised: 09 09 2021
accepted: 13 09 2021
entrez: 3 12 2021
pubmed: 4 12 2021
medline: 3 2 2022
Statut: ppublish

Résumé

Mediterranean diet may be beneficial for inflammatory bowel disease (IBD). The aim of this study was to evaluate the level of adherence to MD in Italian patients with IBD. Eighty consecutive outpatients with IBD, 62 with Crohn's Disease (CD) and 18 with Ulcerative Colitis (UC) were included in the study. Demographic and clinical data, previous and current medical history, nutritional status and Quality of Life (QoL) assessed with the Short Inflammatory Bowel Disease Questionnaire (SIBDQ) were assessed. Adherence to MD was studied with the Medi-Lite questionnaire. IBD patients reported a mean Medi-Lite score of 10.4 with no significant differences between CD and UC patients (p = 0.543). Among CD patients, adherence to MD was higher in patients with inactive disease (p < 0.001) than in patients during the active phase, while no significant difference was found regarding disease activity in UC patients. A significant negative correlation of the Medi-Lite score with SIBDQ score (r = -0.2; p = 0.040) was found. MD adherence was lower in CD patients who had undergone ≥2 surgeries, whereas for patients with UC we found no significant differences in MD adherence in relation to pervious surgery. Adherence to MD in IBD is influenced by disease activity, QoL and patients' surgical history. A greater adherence to MD achieved with nutritional education may help improve quality of life and modulate disease activity.

Sections du résumé

BACKGROUND & AIMS
Mediterranean diet may be beneficial for inflammatory bowel disease (IBD). The aim of this study was to evaluate the level of adherence to MD in Italian patients with IBD.
METHODS
Eighty consecutive outpatients with IBD, 62 with Crohn's Disease (CD) and 18 with Ulcerative Colitis (UC) were included in the study. Demographic and clinical data, previous and current medical history, nutritional status and Quality of Life (QoL) assessed with the Short Inflammatory Bowel Disease Questionnaire (SIBDQ) were assessed. Adherence to MD was studied with the Medi-Lite questionnaire.
RESULTS
IBD patients reported a mean Medi-Lite score of 10.4 with no significant differences between CD and UC patients (p = 0.543). Among CD patients, adherence to MD was higher in patients with inactive disease (p < 0.001) than in patients during the active phase, while no significant difference was found regarding disease activity in UC patients. A significant negative correlation of the Medi-Lite score with SIBDQ score (r = -0.2; p = 0.040) was found. MD adherence was lower in CD patients who had undergone ≥2 surgeries, whereas for patients with UC we found no significant differences in MD adherence in relation to pervious surgery.
CONCLUSIONS
Adherence to MD in IBD is influenced by disease activity, QoL and patients' surgical history. A greater adherence to MD achieved with nutritional education may help improve quality of life and modulate disease activity.

Identifiants

pubmed: 34857229
pii: S2405-4577(21)01050-0
doi: 10.1016/j.clnesp.2021.09.726
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

416-423

Informations de copyright

Copyright © 2021 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest No Conflicts of Interest were present and Ethical Adherence was applied. On behalf of all authors, the corresponding author states that there is no conflict of interest. The authors declare that the manuscript has not been submitted to any other journal.

Auteurs

Camilla Fiorindi (C)

Department of Health Science, AOUCareggi, Florence, Italy.

Monica Dinu (M)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Elena Gavazzi (E)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Stefano Scaringi (S)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Ferdinando Ficari (F)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Anita Nannoni (A)

Department of Health Science, AOUCareggi, Florence, Italy.

Francesco Sofi (F)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Francesco Giudici (F)

Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. Electronic address: francesco.giudici@unifi.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH